tirzepatide medicaid coverage 📢 New Resource Alert! We've added an important update to our Resource Library: Changes to GLP‑1 under Pennsylvania If you or someone you support uses GLP‑1 medications and you are Medicaid Coverage of and Spending

Weight regain after discontinuation is not a personal failure

International pricing variations for peptide drugs can be substantial, reflecting differences in healthcare systems, regulatory requirements, and market dynamics across countries

We are excited to share new insights that may benefit the many women living with obesity. Weight loss and heart health data In a post-hoc analysis of the STEP UP trial, premenopausal women with obesity lost an average of 22.6% of their body weight on once-weekly high-dose Wegovy (semaglutide 7.2 mg) with over 4 in 10 (41.4%) achieving exceptional 25% or more weight loss, compared with placebo

Breakfast is emerging as the most disrupted meal occasion, with many users eating just one or two meals a day